Start A Thread

Rate Bioventus

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

Has Titan Medical missed their opportunity with SPORT?

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

FDA clears AliveCor’s KardiaBand as the first medical device accessory for the Apple Watch

TransEnterix sells first Senhance Robotic System to Florida Hospital. Is SurgiBot up Next?

What was a Surgeon's First Impression of the Senhance Robotic System?

Will New Stent Study Negatively Impact Boston Scientific and Medtronic?

Intersect ENT's Sinus Implant Proves Effective, But Is It Too Expensive?

Medtronic and Mazor Robotics Need Each Other

Plaintiffs Lawyer Suggests Witness Tampering in Depuy Hip Implant Trial

Can TransEnterix overtake Intuitive Surgical in the robotic surgery race?

Is Depuy's Attune Knee System Having Loosening Issues?

Job Listings

RIP Exogen, Part Deux

2 months ago

Coverage reductions and management decisions are bringing this glorious product to a slow death.

Goodbye my special friend. Good bye.

Bioventus News

3 months ago

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN

Durham, NC- September 13, 2017 - Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES (Bioventus Observational Non-interventional EXOGEN Studies) clinical development program. BONES includes three observational, non-interventional, direct-to-patient studies designed to collect real world data on the use of the EXOGEN Ultrasound Bone Healing System. EXOGEN uses safe, e…

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN® Durham, NC– September 13, 2017 – Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES (Bioventus Observational Non-interventional EXOGEN Studies) clinical development program. BONES includes three observational, non-interventional, direct-to-patient studies designed to collect real world data on the use of

Bioventus Delays IPO

1 year ago

Bioventus Delays IPO

Bioventus, a global leader in orthobiologics, postponed their IPO on Friday.The Durham, NC based company filed for their initial public offering in early July hoping to raise $150 million by offering 8.8 million shares at a price range of $16 to $18.

ES Reps, 2015 and Beyond

3 years ago

Yes. Everyone is going to go work for DJ Ortho and BV will crumble.

Bioventus is Now a Stepping Stone

3 years ago

I feel like we're always hiring due to so many departures. I noticed a bunch of positions posted online for reps.

Loading...